Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Free Cash Flow (2023 - 2025)

Historic Free Cash Flow for Profound Medical (PROF) over the last 3 years, with Q3 2025 value amounting to -$9.6 million.

  • Profound Medical's Free Cash Flow fell 4084.38% to -$9.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$37.5 million, marking a year-over-year decrease of 5066.46%. This contributed to the annual value of -$23.5 million for FY2024, which is 373.3% down from last year.
  • According to the latest figures from Q3 2025, Profound Medical's Free Cash Flow is -$9.6 million, which was down 4084.38% from -$13.7 million recorded in Q2 2025.
  • In the past 5 years, Profound Medical's Free Cash Flow ranged from a high of $5.8 million in Q1 2023 and a low of -$26.2 million during Q3 2023
  • Moreover, its 3-year median value for Free Cash Flow was -$6.8 million (2024), whereas its average is -$7.1 million.
  • Examining YoY changes over the last 5 years, Profound Medical's Free Cash Flow showed a top increase of 7396.84% in 2024 and a maximum decrease of 22148.86% in 2024.
  • Quarter analysis of 3 years shows Profound Medical's Free Cash Flow stood at -$7.3 million in 2023, then rose by 19.78% to -$5.9 million in 2024, then crashed by 63.53% to -$9.6 million in 2025.
  • Its Free Cash Flow was -$9.6 million in Q3 2025, compared to -$13.7 million in Q2 2025 and -$8.3 million in Q1 2025.